Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-Centre, Phase III, Subject Initiated Safety Study of ME-609 in Treatment of Recurrent Herpes Simplex Labialis in Adolescents

NCT00375570 is registered in ClinicalTrials.gov with Medivir as lead sponsor.

NCT NCT00375570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-Centre, Phase III, Subject Initiated Safety Study of ME-609 in Treatment of Recurrent Herpes Simplex Labialis in Adolescents
Lead sponsor
Medivir
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2006
Completion date
September 30, 2007
Enrollment
254 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis